Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature

BACKGROUND: Ajmaline is a pharmaceutical agent now administered globally for a variety of indications, particularly investigation of suspected Brugada syndrome. There have been previous reports suggesting that repetitive use of this agent may cause severe liver injury, but little evidence exists dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullish, Benjamin H, Fofaria, Rishi K, Smith, Belinda C, Lloyd, Kirsty, Lloyd, Josephine, Goldin, Robert D, Dhar, Ameet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977671/
https://www.ncbi.nlm.nih.gov/pubmed/24694003
http://dx.doi.org/10.1186/1471-230X-14-60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977671/
https://www.ncbi.nlm.nih.gov/pubmed/24694003
http://dx.doi.org/10.1186/1471-230X-14-60

Ejemplares similares